Toxicology – Neuroleptic Malignant Syndrome (NMS)

Definition

Neuroleptic malignant syndrome is a life-threatening reaction associated with severe dopamine blockade. It is classically characterized by:

• Hyperthermia
• Altered mental status
• Autonomic instability
• Severe muscle rigidity

It can occur even at therapeutic antipsychotic doses and often evolves over 1–3 days.

Common Causes

NMS is most often associated with:

• Antipsychotic medications, especially potent dopamine antagonists
• Rapid dose escalation
• Parenteral antipsychotic use
• Abrupt withdrawal of dopaminergic therapy in patients with Parkinson disease

Mechanism of Action

The syndrome is thought to result from marked reduction in dopamine activity, particularly in the hypothalamus and basal ganglia.

This leads to:

• Impaired temperature regulation
• Severe muscle rigidity
• Autonomic dysfunction
• Altered mental status

Clinical Features

Typical findings include:

• High fever
• Tachycardia
• Hypertension or labile blood pressure
• Tachypnea
• Diaphoresis
• Confusion or decreased consciousness
• “Lead-pipe” muscular rigidity
• Bradykinesia
• Leukocytosis
• Elevated creatine kinase (CK)
• Rhabdomyolysis

Complications can include acute kidney injury, dysrhythmias, respiratory failure, and shock.

Differential Diagnosis

Important mimics include:

• Serotonin syndrome
• Malignant hyperthermia
• Anticholinergic toxicity
• Sympathomimetic toxicity
• Severe infection or encephalopathy

A useful distinction is:

• NMS: lead-pipe rigidity, bradykinesia, elevated CK, slower onset
• Serotonin syndrome: clonus, hyperreflexia, GI symptoms, faster onset
• Anticholinergic toxicity: dry skin and mucous membranes rather than diaphoresis

Management

Treatment is mainly supportive:

• Immediately stop the offending dopamine-blocking drug
• Airway and cardiovascular support as needed
• IV fluids
• Active cooling for hyperthermia
• Benzodiazepines for agitation

Additional therapies sometimes used in severe cases include:

• Dantrolene to reduce muscle rigidity and heat production
• Bromocriptine or another dopamine agonist to restore dopaminergic activity

Close monitoring is needed for rhabdomyolysis, renal injury, electrolyte disturbances, and cardiac complications.

Key Points

• Think of fever + rigidity + autonomic instability + altered mental status.
• Lead-pipe rigidity strongly favors NMS over serotonin syndrome.
• CK elevation and rhabdomyolysis are common.
• Early recognition and withdrawal of the causative drug are critical.
• Symptoms often develop over days rather than within a few hours.